David Shaw’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,490
Closed -$153K 4968
2024
Q2
$153K Sell
13,490
-7,094
-34% -$94.4K ﹤0.01% 4119
2024
Q1
$295K Sell
20,584
-68,577
-77% -$972K ﹤0.01% 3737
2023
Q4
$1.22M Buy
+89,161
New +$939K ﹤0.01% 3010
2023
Q2
Sell
-64,382
Closed -$515K 4643
2023
Q1
$515K Sell
64,382
-76,007
-54% -$782K ﹤0.01% 3544
2022
Q4
$1.59M Sell
140,389
-21,407
-13% -$234K ﹤0.01% 3114
2022
Q3
$1.41M Buy
161,796
+20,228
+14% +$210K ﹤0.01% 3319
2022
Q2
$1.41M Buy
141,568
+28,079
+25% +$283K ﹤0.01% 3377
2022
Q1
$1.14M Buy
113,489
+96,657
+574% +$1.03M ﹤0.01% 3796
2021
Q4
$213K Buy
+16,832
New +$219K ﹤0.01% 4855
2021
Q3
Sell
-19,433
Closed -$293K 5291
2021
Q2
$293K Buy
+19,433
New +$292K ﹤0.01% 4290

Other funds holding PTVE

David Shaw's PTVE Position: Q3 2024 in Review

David Shaw sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q3 2024, closing a stake of 13,490 shares — an estimated $153K sold.

David Shaw first reported a position in PTVE in Q2 2021 and held it in 10 quarters. The position peaked at $1.59M in Q4 2022. 137 funds tracked by Wall St. Rank hold PTVE as of Q3 2024.

  • David Shaw reported no remaining Pactiv Evergreen Inc. Common stock position as of Q3 2024 after selling out during the quarter.
  • David Shaw sold 13,490 Pactiv Evergreen Inc. Common stock shares in Q3 2024, an estimated $153K.
  • David Shaw first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2021 and held it in 10 quarters.
  • David Shaw's Pactiv Evergreen Inc. Common stock position peaked at $1.59M in Q4 2022.
  • 137 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.